Ausländische Medikamente - In der EU bewilligte Medikamente sollen ohne weitere Prüfung auch in der Schweiz zugelassen werden: Die Heilmittelbehörde Swissmedic erwägt, diesen brisanten Vorschlag bereits im April dem Bundesrat zu unterbreiten more
Informa's Annual Immunogenicity for Biologics conference is back in February 2010 to answer the most pressing issues facing the success of your immunogenicity testing strategies:
How do I interpret and report immunogencity data during clinical trials?
What impact with the forthcoming EMEA Immunogenicity Guideline for MAbs have on my business?
How should I develop reliable, robust and validated assays?
Do we need methods for the detection of IgE ADAs?
What other assay formats are available?
How can I engineer my proteins to reduce unwanted immunogenicity?
What impact does protein aggregation have on product development, and what can I do to screen for it?
